Reproductive health risks in perspective

Contraception

Volumn 73, Issue 5, 2006, Pages 437-439

  Trussell, James ^a   Jordan, Beth ^b  

^a PRINCETON UNIVERSITY   (United States)

^b Association of Reproductive Health Professionals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; ESTROGEN; ORAL CONTRACEPTIVE AGENT; ORTHOEVRA; UNCLASSIFIED DRUG;

ABORTION; BREAST CANCER; CANCER RISK; COLORECTAL CANCER; CONTRACEPTION; DEATH; DELIVERY; DRUG FATALITY; EDITORIAL; ENDOMETRIUM CANCER; FERTILITY; HEALTH HAZARD; HEART INFARCTION; HUMAN; LIVER CANCER; LONG TERM EXPOSURE; OVARY CANCER; PREGNANCY COMPLICATION; REPRODUCTIVE HEALTH; RISK FACTOR; SPONTANEOUS ABORTION; STROKE; TRANSDERMAL PATCH; TREATMENT FAILURE; UNPLANNED PREGNANCY; UTERINE CERVIX CANCER; VENOUS THROMBOEMBOLISM;

ABORTION, INDUCED; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HUMANS; PREGNANCY; RISK;

EID: 33646051195     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2006.01.008     Document Type: Editorial

References (15)

1. Laudan L. The book of risks (1994), John Wiley and Sons, New York
2. Schwingl P.J., Ory H.W., and Visness C.M. Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States. Am J Obstet Gynecol 180 (1999) 241-249
3. Escobedo L.G., Peterson H.B., Grubb G.S., and Franks A.L. Case-fatality rates for tubal sterilization in U.S. hospitals, 1979-1980. Am J Obstet Gynecol 160 (1989) 147-150
4. Hajjeh R.A., Reingold A., Weil A., Shutt K., Schuhat A., and Perkins B.A. Toxic shock syndrome in the United States, 1979-1996. Emerg Infect Dis 5 (1999) 807-810
5. U.S. Bureau of the Census. Statistical abstract of the United States: 2003 (2003), Government Printing Office, Washington (DC) [Table 11]
6. Berg C.J., Chang J., Callaghan W.M., and Whitehead S.J. Pregnancy-related mortality in the United States, 1991-1997. Obstet Gynecol 101 (2003) 289-296
7. Saraiya M., Green C.A., Berg C.J., Hopkins F.W., Koonin L.M., and Atrash H.K. Spontaneous abortion-related deaths among women in the United States - 1981-1991. Obstet Gynecol 94 (1999) 172-176
8. Personal communication from Danco Laboratories, C Summers. 9 March 2006.
9. Bartlett L.A., Berg C.J., Shulman H.B., et al. Risk factors for legal induced abortion-related mortality in the United States. Obstet Gynecol 103 (2004) 729-737
10. Burkman R., Schlesselman J.J., and Zieman M. Safety concerns and health benefits associated with oral contraception. Am J Obstet Gynecol 190 Suppl (2004) S5-S22
11. Marchbanks P.A., McDonald H.G., Wilson H.G., et al. Oral contraceptives and the risk of breast cancer. N Engl J Med 346 (2002) 2025-2032
12. Smith J.S., Green J., Berrington de Gonzalez A., et al. Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet 361 (2003) 1159-1167
13. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet 347 (1996) 1713-1727
14. Ortho-McNeil Pharmaceutical. Ortho Evra Product labeling. Revised November 2005.
15. Media report on Ortho Evra patch sets off safety concerns in women. Contracept Technol Update 26 (2005) 113-115